Investigational Site Number : 7240010

Esplugues de Llobregat, Catalunya [Cataluña] 08950

0 studies enrolling now · 2 studies all time

What they study most

Chronic Spontaneous Urticaria, Dermatitis Atopic

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids — Completed
• Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) — Completed